Christopher Rovaldi
Overview
Christopher Rovaldi received $4M in total compensation, including $435K in salary, at Keros Therapeutics in 2022.
Source: SEC filing on April 24, 2023.
Related executives
We found four more executives who work or worked at Keros Therapeutics.